Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK3 | O14649 | 6/20 | 0.58 |
| ▸ | RHOC | P08134 | 1/20 | 0.57 |
| ▸ | RHOA | P61586 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 2/20 | 0.49 |
| ▸ | PPARD | Q03181 | 2/20 | 0.49 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.49 |
| ▸ | PPARA | Q07869 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.49 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.49 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.49 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1822021 | 0.92 | KCNK3 (0.57) | KCNK3RHOCRHOARXFP1ABCC9 | |
| SCHEMBL2103913 | 0.91 | KCNK3 (0.57) | KCNK3NR1H4ABCC9ABCC8KCNJ11 | |
| SCHEMBL2260386 | 0.90 | MEN1 (0.56) | KCNK3KCNJ11MEN1KMT2ARAB9A | |
| SCHEMBL1821577 | 0.86 | KCNK3 (0.58) | KCNK3KCNJ11MEN1KMT2ARAB9A | |
| SCHEMBL2261736 | 0.86 | KCNK3 (0.60) | KCNK3RXFP1KCNJ11MEN1KMT2A | |
| SCHEMBL1820976 | 0.84 | ALDH1A1 (0.49) | KCNK3RHOCRHOARXFP1ABCC9 | |
| SCHEMBL1813161 | 0.83 | KCNK3 (0.52) | KCNK3RHOCRHOAPPARGPPARD | |
| SCHEMBL1819735 | 0.83 | KMT2A (0.55) | KCNK3RXFP1MEN1KMT2AMAPT | |
| SCHEMBL2105409 | 0.83 | MEN1 (0.58) | KCNK3RXFP1MEN1KMT2ARAB9A | |
| SCHEMBL2104794 | 0.81 | KCNK3 (0.56) | KCNK3NR1H4MEN1KMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110201603-A1 | Novel Acylaminobenzamide Derivatives | BAYER CROPSCIENCE AG (DE) | 2011-08-18 | — | — | US | disclosed |
| EP-2318358-A2 | ACYLAMINOBENZAMIDE DERIVATIVES | Bayer CropScience AG (DE) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010015355-A2 | NOVEL ACYLAMINOBENZAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2010-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201603-A1 | Novel Acylaminobenzamide Derivatives | KCNB1, KCNA5, KCNA7 | KCNK3 174/4885RHOC 2828/4885RHOA 3401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.